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ABSTRAK
Osteoartritis (OA) merupakan penyakit sendi degeneratif tersering pada usia lanjut. Pilihan obat yang 
direkomendasikan oleh American Academy of Orthopaedic Surgeon (AAOS) adalah asetaminofen, OAINS, 
tramadol, capscaicin dan kortikosteroid intraartikular. Meskipun demikian, sejumlah efek samping akibat 
pemakaian jangka panjang obat tersebut cukup mengkhawatirkan. Para peneliti saat ini sedang mencari 
modalitas terapi yang lebih aman untuk OA. Terapi lintah (hirudoterapi) merupakan salah satu terapi yang 
sedang diteliti mengingat sifat analgesik dan anti-inflamasi yang dimilikinya. 
Kata kunci: osteoartritis, hirudoterapi, terapi lintah, OAINS, usia lanjut, terapi alternatif.
ABSTRACT
Osteoarthritis (OA) is the most common degenerative joint disease found in the elderly. Drug options that 
are recommended by the American Academy of Orthopaedic Surgeon (AAOS) are acetaminophen, NSAIDs, 
tramadol, capscaicin and intraarticular corticosteroids. However, there is concern for the possible side effects 
resulting from long term use of those medications. Researchers are searching for a safer treatment modality for 
OA. Leech therapy (hirudotheraphy) is one of the therapies under investigation, given its purported analgesic 
and antiinflammatory properties.
Key words: osteoarthritis, hirudotherapy, leech therapy, NSAIDSs, elderly, alternative terapy.
INTRODUCTION
Osteoarthritis (OA) is the most common 
degenerative joint disease found in the elderly. 
This disease is characterized by articular cartilage 
degeneration, peripheral bone hypertrophy 
and synovial membrane changes. Common 
symptoms are joint pain after activity and 
stiffness after periods of immobility, including 
sleep.1 Therapeutic approaches to OA involve 
both physiotherapy and pharmacotherapy, but 
the use is limited by expense and side effects.2 
Pharmacologic therapies recommended by the 
ACR (American College of Rheumatology) and 
the AAOS (American Academy of Orthopaedic 
Surgeons) include acetaminophen, oral and topical 
NSAIDSs (Non-steroidal Anti-Inflammatory 
Drugs), tramadol, capsaicin and intra-articular 
corticosteroids.3,4 Additionally, they recommended 
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physical activity, thermal therapy and joint support 
devices.3 Recent research showed Hirudotherapy 
(leech therapy) could reduce pain from knee OA.2,5 
It has been proposed that Hirudotherapy has 
better efficacy and a favorable side-effect profile 
compared to NSAIDSs.6 This review aims to 
describe the use of Hirudotherapy as an alternative 
therapy for OA.
OSTEOARTHRITIS
Osteoarthritis (OA) is the most common 
arthritis, affecting one in five US adults. It is 
particularly problematic source of disability 
among the elderly, afflicting 49.7% of US 
persons >65 years old.  The magnitude of this 
problem is expected to increase commensurate 
with the global increase in the elderly (>65 
years) population. In the US alone, elders are 
projected to comprise 19% of the population by 
2030, at which time 67 million cases of OA are 
anticipated among US adults >18 years old.7,8
The objectives of OA management are pain 
relief and optimization of physical activity. 
Comprehensive OA management is multimodal, 
including pharmacologic and non-pharmacologic 
therapy.
Non-pharmacologic Therapy 
Non-pharmacologic therapies recommended 
by the AAOS (American Academy of Orthopaedic 
Surgeons) are joint enhancement programs, joint 
sparing aerobic sports, neuromuscular education 
and weight loss for overweight patients (BMI 
≥25).4
Pharmacologic Therapy
Drugs that are recommended by the 
AAOS are acetaminophen, oral and topical 
NSAIDSs, tramadol, capsaicin and intra-articular 
corticosteroids for symptomatic patients.4
Prompted in part by the side effects of long 
term NSAID use, researchers are investigating 
leech therapy (hirudotheraphy) as an alternative 
treatment for OA. Leech saliva has analgesic 
and anti-inflammatory substances which may 
be beneficial.9,10
COMPOSITION OF LEECH SALIVA
Various components of leech saliva may 
have potential for clinical application, given 
their anticoagulant and antimicrobial properties.11 
Leech saliva has activity against E. coli, P. 
aeruginosa, B. cereus, S. Typhy and S. Aureus) and 
the fungi C. albicans and C. neoformans. Leech 
saliva also has analgesic and anti-inflammatory 
substances which may be useful for OA treatment.
Some of components of leech saliva are 
shown in Table 1.12
ANALGESIC PROPERTIES OF LEECH SALIVA
Several studies showed analgesia from 
Hirudotherapy is superior to that from natrium 
diclofenac.6 There are multiple suggested means 
by which leech saliva may effect analgesia. 
As detailed in Table 1, several substances in 
leech saliva have properties which together 
may contribute to analgesia, including hirudin 
(thrombin inhibitor), histamine-like vasodilator, 
kalikrein, triptase and other proteinase inhibitors, 
and hialuronidase.9,13–17
A second hypothesis is leech saliva could 
reduce pain through antinociceptive effects.6 
One study found that hirudin can inhibit platelet 
derived growth factor (PDGF),  a factor involved 
in pain induction.18
Another hypothesis proposes that joint 
inflammation (and consequently pain) could 
be reduced by the anti-inflammatory action of 
bdellins and eglins in leech saliva. Leech saliva 
also contains hirudin-, calin-, and destabilase-
like substances that increase microcirculation 
by decreasing blood viscosity. By decreasing 
inflammation and increasing microcirculation, 
joint stiffness and restriction may decrease.9
CONTRAINDICATIONS, SAFETY AND 
COMPLICATIONS OF HIRUDOTHERAPY
Contraindications to Hirudotherapy include 
blood coagulation disorders, severe anemia, 
allergy to leech saliva, pregnancy and frailty. 
A patient’s bleeding and clotting times must 
be established as normal prior to initiating 
hirudotherapy.19-23
Infection is the most common complication 
of Hirudotherapy, affecting 2-36% of patients.24 
Common bacteria encountered are Aeromonas 
spp., Pseudomonas spp. and Vibrio spp. We 
recommend preventive treatment with oral 
antibiotic prophylaxis.25
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Other reported complications are a range 
of local hypersensitivity reactions, described 
as mild itching, blister formation, ulcerative 
necrotic lesion, and/or local tissue destruction.6,10 
Some patients also reported prolong bleeding or 
persistent skin lesions from incomplete healing 
at the leech attachment site.24
HIRUDOTHERAPY FOR OSTEOARTHRITIS: 
CURRENT EVIDENCE
A systematic review and meta-analysis 
regarding the use of Hirudotherapy for knee OA 
done by Lauche R, et al.2 from three randomized 
control trials (RCT) and one non-randomized 
clinical control trial (CCT), showed moderate 
to strong evidence for the reduction of pain, 
functional impairment and joint stiffness after 
hirudotherapy of 237 patients with knee OA.2
An RCT by Michalsen A, et al.9 showed 
significant reductions in pain and stiffness, as 
well as improved joint function.9 Among 51 
patients with knee OA, 24 received 4-6 sessions 
of leech therapy, while 27 patients were given 
topical diclofenac for 28 days. This research 
showed on day-7 of treatment pain in leech 
therapy group was decreased from average score 
53.5 +/- 13.7 (+/-SD) unto 19.3 +/- 12.2  (+/-SD), 
while pain reduction from topical diclofenac 
use decreased from 51.5 +/- 16.8 (+/-SD) unto 
42.4 +/- 19.7 (+/-SD) [95% CI, -32.8 to -15.1]; 
P<0.001). However, further follow-up revealed 
no significant pain difference between leech 
therapy and topical diclofenac arm.9 This result 
should be interpreted with cautious, given some 
methodical weaknesses encountered: small 
number of patients, non-blinded study, subjective 
outcome measurement, possible placebo effect, 
and non-standard treatment comparison. No 
serious adverse event reported from this research.
Andereya, et al10 tried to correct the 
methodological weaknesses of the previous 
study with a new RCT of 113 patients with 
severe knee OA. Patients were randomized 
unto 3 groups: Group I (n=38) received a single 
session of leech therapy. Group II (n=35) had 
two hirudotherapy sessions, separated by four 
weeks. The treatment of control group (n=40) 
was simulated with an “artificial leech”. Results 
were documented with the Knee injury and 
Osteoarthritis Outcome Score, Western Ontario 
and McMaster osteoarthritis index and the 
Visual Analog Score for pain. Improvement in 
each of these measures was found in all three 
groups. These improvements were statistically 
significant for treatment groups I and II during 
follow-up. Group II (treated twice with leeches) 
Table 1. Component in leech Saliva12
Components Functions
Hirudin Inhibits blood coagulation by binding to thrombin
Calin 
Inhibits blood coagulation by blocking the binding of von Willebrand factor to collagen. 
Inhibits collagen-mediated platelet aggregation
Destabilase Monomerizing activity. Dissolves fibrin. Thrombolytic effects
Hirustasin Inhibits kallikrein, trypsin, chymotrypsin, neutropholic cathepsin G
Bdellins Anti-inflammatory. Inhibits trypsin, plasmin, acrosin
Hyaluronidase Increases interstitial viscosity. Antibiotic
Tryptase Inhibitor Inhibits proteolytic enzymes of host mast cells
Eglins 
Anti-inflammatory. Inhibit the activity of alpha-chymotrypsin, chymase, substilisin, 
elastase, cathepsin G
Factor Xa inhibitor Inhibits the activity of coagulation factor Xa by forming equimolar complexes
Complement inhibitors May replace natural complement inhibitors if they are deficient
Carboxypeptidase A inhibitors Increases the inflow of blood at the bite site
Histaminelike substances Vasodilator. Increases the inflow of blood at the bite site
Acetylcholine Vasodilator
Anesthetics substances Anesthetic
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demonstrated the greatest degree of improvement, 
with both long term reduction of joint stiffness 
and improved function in the activities of daily 
living. Repeated use of leeches appeared to make 
the improvement of symptoms more durable. 
The most frequent side effect described in this 
study was local irritation, which had receded by 
the follow-up evaluation at 4 weeks. Given other 
studies’ lack of positive findings, one questions 
to what degree the benefits noted in this trial 
stem from the activity of leech saliva versus the 
placebo effect or other uncontrolled bias from 
expectations placed on an unusual treatment.10
HIRUDOTHERAPY IN INDONESIA
Until recently, no official agency exists in 
Indonesia to supply standardized medicinal 
leeches although Indonesia has a big population 
of leeches. Hirudotherapy has not been routinely 
used in hospitals, and to our knowledge only by 
alternative medicine therapists.
CONCLUSION
Osteoarthritis (OA) is one of the most 
common causes of joint discomfort and disability. 
Since its prevalence increases with age, the 
global rise in the geriatric population portends an 
increased burden of this disease on individuals 
and the health care system. Hirudotherapy may 
offer another therapeutic option to reduce the 
pain and debility caused by OA. However, 
additional studies with robust methodology 
and adequate sample size are needed to better 
evaluate whether hirudotherapy should be among 
standard clinical practice for OA treatment.
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